$NVDA Multiple Compression Ahead of Inference Cycle

 The.Ticker.Guru
 
  The.Ticker.Guru
 
Follow  Message
 
 
 
Rising.Stars identifying stocks that finish the trading day with impressive gains. With a focus on market dynamics and late-day trading patterns.
 

•  17 Feb 2026
 

•   AMD  
   
  +0.85%
•   AMZN  
   
  +0.20%
•   AVGO  
   
  +1.52%
•   META  
   
  +0.43%
•   NVDA  
   
  +1.55%

$NVDA trades near $183 with consensus targeting $260, implying 41% upside, yet the forward multiple of roughly 23x on projected FY2027 EPS of $7.7 places the stock at a discount to several semiconductor peers despite materially higher growth. Street models call for ~$65B in quarterly revenue and $1.49 EPS in the upcoming print, reflecting 67% year-over-year growth. The setup is not about whether growth is strong; it is about duration, mix shift, and capital intensity.

Last quarter’s $57B in revenue, including $51B from data center, confirmed that hyperscale AI capex is still translating into orders. With companies such as $AMZN and $META committing over $200B annually to infrastructure expansion, aggregate AI spend could approach $660B in 2026. The consensus narrative frames this as late-cycle exuberance. The market’s price action suggests a different concern: the timing mismatch between capex deployment and downstream monetization. That is why multiple compression has occurred even as estimates have risen.

The structural pivot from training to inference is underappreciated in near-term positioning. Nvidia’s Blackwell architecture, with materially improved performance per watt and reported cost reductions of roughly 35% per million tokens processed, shifts the conversation from peak cluster buildouts to recurring, efficiency-driven deployment. Inference demand is less episodic than training waves and more tightly integrated into enterprise workflows. If that transition sustains, revenue visibility improves even as headline capex moderates.

Competition risk from $AMD and $AVGO is real, yet Nvidia retains roughly 80% share in AI accelerators. The more nuanced risk lies in geopolitics and channel mix. Export controls have likely created an estimated $30B revenue gap tied to China. However, incremental approvals and indirect demand channels may already be softening that drag. If China re-enters the demand stack even partially, estimate revisions could skew upward, not because of incremental hype but because of recovered volume.

Technically $NVDA has corrected meaningfully from prior highs and is consolidating while earnings estimates trend higher. That divergence between price momentum and earnings trajectory is typically resolved in one of two ways: either estimates flatten to validate the lower multiple, or price re-rates toward earnings power. Current flows suggest institutions are not exiting wholesale but rotating within the AI complex, trimming duration-sensitive exposure while maintaining core allocation to dominant platforms.

The edge lies in recognizing that $NVDA is no longer priced as an exponential story but as a high-growth company with execution risk. At 23x forward earnings with revenue growth projected near 58% next fiscal year, the stock embeds skepticism about capex sustainability and geopolitical leakage. If upcoming results confirm sustained data center momentum and inference-driven mix improvement, the multiple could expand modestly even without further estimate upgrades. If guidance signals deceleration tied to hyperscale digestion, compression continues.

The market is debating whether AI spending is peaking positioning suggests smart money is pricing normalization rather than collapse. The next catalyst is not the headline EPS beat, but guidance around order cadence, backlog visibility, and China exposure. That is where the asymmetry sits for $NVDA.

View All Headlines